NCT02180854

Brief Summary

Acute deterioration among hospitalised patient can result in serious adverse events like cardiac arrest, unexpected death or unanticipated intensive care unit (ICU) admission. Most events are preceeded by deteriorating vital signs, and potentially avoidable. To detect and treat hospitalised at-risk patients early an early warning score (EWS) was introduced at the investigator site. EWS measures of a number of physiological parameters that are aggregated to a common score, that directs monitoring frequency, clinical interventions and competency of the provider. Patients with low scores (0 - 1) are monitored every 12th hour and seldom experience serious adverse events. The optimal monitoring frequency for this group is unknown, and presently based on a compromise between patient safety and work load issues. The aim of the present study is to explore if an 8 hourly monitoring interval (intervention) is correlated with a better outcome than 12 hour intervals (control), based on the number of patients that deteriorate to a higher EWS 24 hours after hospital admission in each group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 3, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

February 9, 2015

Status Verified

February 1, 2015

Enrollment Period

3 months

First QC Date

June 27, 2014

Last Update Submit

February 6, 2015

Conditions

Keywords

Early warning scoreRapid response systemsMedical emergency team

Outcome Measures

Primary Outcomes (1)

  • Number of patients with an EWS >/= 2

    Clinical deterioration is correlated to elevated EWS

    24 hours after first EWS after admission

Secondary Outcomes (6)

  • Number of patients with an aggregated score of EWS >/= 5 or >/= 7

    24 to 48 hours

  • EWS >/ = 2

    48 hours

  • Mortality

    72 hours and 30 days

  • Length of hospital stay

    30 days

  • Number of patients with an individual score of EWS >/= 3

    24 to 48 hours after first EWS on admission

  • +1 more secondary outcomes

Other Outcomes (3)

  • Number of EWS measurements performed during first 48 hours of admission

    48 hours

  • Number of MET calls during first 72 hours of admission

    72 hours

  • Number of patients where escalation protocol is adhered to

    48 hours

Study Arms (2)

Intervention (8 hours)

EXPERIMENTAL

EWS every 8 hours

Other: Increased monitoring frequency

Control (12 hours)

ACTIVE COMPARATOR

EWS every 12 hours

Other: Control group

Interventions

Control (12 hours)
Intervention (8 hours)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first EWS on admission = 0 or 1
  • age \>/ = 18 years

You may not qualify if:

  • chronically elevated EWS
  • terminal disease and comfort care only
  • conditions that warrant closer observation according to hospital guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg University Hospital

Copenhagen, 2400, Denmark

Location

MeSH Terms

Conditions

Death, Sudden

Interventions

Control Groups

Condition Hierarchy (Ancestors)

DeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • John A Petersen, MD

    Bispebjerg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Consultant in Critical Care Medicine

Study Record Dates

First Submitted

June 27, 2014

First Posted

July 3, 2014

Study Start

September 1, 2014

Primary Completion

December 1, 2014

Study Completion

January 1, 2015

Last Updated

February 9, 2015

Record last verified: 2015-02

Locations